Correspondence 0001493152-24-018222 from Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE)

Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: May 8, 2024 · CIK: 0001401914 · Accession: 0001493152-24-018222

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-278380

Date

May 8, 2024

Author

Daré

Form

CORRESP

Company

Dare Bioscience, Inc. (DARE) (CIK 0001401914)

Letter

Daré Bioscience, Inc.

Nobel Drive, Suite 260

San Diego, California 92122

May 8, 2024

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporate Finance

F Street, NE

Washington, DC 20549

Attn: Daniel Crawford

Re: Daré Bioscience, Inc.

Registration Statement on Form S-3 (File No. 333-278380)

Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Daré Bioscience, Inc. hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced registration statement to Friday, May 10, 2024, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable.

If you have any questions regarding this request, please contact Scott Stanton of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. at (858) 314-1880.

Sincerely,
Daré
Bioscience, Inc.

Show Raw Text

CORRESP
1
filename1.htm

Daré
Bioscience, Inc.

3655
Nobel Drive, Suite 260

San
Diego, California 92122

May
8, 2024

Via
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporate Finance

100
F Street, NE

Washington,
DC 20549

Attn:
Daniel Crawford

    Re:
    Daré
    Bioscience, Inc.

    Registration
    Statement on Form S-3 (File No. 333-278380)

    Acceleration
    Request

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the Securities Act of 1933, as amended, Daré Bioscience, Inc. hereby respectfully requests that the Securities
and Exchange Commission accelerate the effective date of the above-referenced registration statement to Friday, May 10, 2024, at 4:01
p.m., Eastern Time, or as soon thereafter as practicable.

If
you have any questions regarding this request, please contact Scott Stanton of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. at
(858) 314-1880.

    Sincerely,

    Daré
    Bioscience, Inc.

    /s/
    MarDee Haring-Layton

    MarDee
    Haring-Layton

    Chief
    Accounting Officer

    cc:
    Mintz,
    Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

    Scott
    Stanton, Esq.

    Jessica
    Zhang, Esq

SecProbe.io